Cara Therapeutics
CARA
$0.66
Share price
-4.20%
Change (1 day)
-84.48%
Change (1 year)
Categories
Operating Margin for Cara Therapeutics (CARA)
Operating Margin as of April 2024 (TTM): -209.07%
According to Cara Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -209.07%. At the end of 2021 the company had an Operating Margin of -384.06%.
Operating Margin history for Cara Therapeutics from 2014 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -384.06% | -6821% |
| 2020 | 5.71% | -101.06% |
| 2019 | -539.02% | -2.42% |
| 2018 | -552.39% | -91.37% |
| 2017 | -6,402.74% | -90.46% |
| 2016 | -67,148.84% | 10079.26% |
| 2015 | -659.66% | 16.78% |
| 2014 | -564.87% | 1592.5% |
| 2013 | -33.38% | -93.7% |
| 2012 | -529.58% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -110.94% | 🇺🇸 USA |
 Pfizer PFE | 34.61% | -116.55% | 🇺🇸 USA |
 Trevena TRVN | -24,856.30% | 11,788.98% | 🇺🇸 USA |
 Recro Pharma
REPH | 4.99% | -102.39% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | -79.07% | -62.18% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -84.50% | -59.58% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.